Injecting drug users (IDUs) are at risk of infection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). Independently, each of these viruses is a serious threat to health, with HIV ravaging the body's immune system, and HCV causing cirrhosis, liver cancer and liver failure. Furthermore, co-infection with HIV/HCV weakens the response to antiretroviral therapy in HIV patients. IDUs with HIV/HCV co-infection are at a 20 times higher risk of having liver-related morbidity and mortality than IDUs with HIV alone. In Viet Nam, studies to ascertain the prevalence of HIV in IDUs have...
Injecting drug users (IDUs) are at risk of infection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). Independently, each of these...